Literature DB >> 30546892

Evaluation of neutrophil-to-lymphocyte ratio and calcitonin concentration for predicting lymph node metastasis and distant metastasis in patients with medullary thyroid cancer.

Nizhen Xu1, Yanbing Jian1, Yaxi Wang1, Wen Tian1.   

Abstract

The aim of the present study was to investigate potential predictive factors of lymph node metastasis (LNM) and distant metastasis (DM) of medullary thyroid cancer (MTC). A total of 61 patients newly diagnosed with MTC at the General Hospital of the Chinese People's Liberation Army between January 2001 and January 2016 were enrolled and divided into two groups according to the results of preoperative examinations and surgical histopathology as follows: Group NM (without metastases), and group M (with metastases). Univariate logistic regression analysis demonstrated that sex, tumor size, preoperative peripheral blood neutrophil-to-lymphocyte ratio (NLR), and concentration of carcinoembryonic antigen (CEA) and calcitonin (Ctn), were significantly associated with LNM and DM. The multivariate analysis revealed that a Ctn concentration of >500 pg/ml [odds ratio (OR)=21.422; 95% confidence interval (CI): 2.611-175.731] and the NLR (OR=5.918; 95% CI: 1.147-30.541) were positively correlated with LNM and DM. The optimal cut-off value of the NLR for predicting LNM and DM obtained from receiver operating characteristic curve analysis was 1.784 (sensitivity 68.3% and specificity 80%), and the area under the curve was 0.717. In conclusion, the findings of the present study strongly suggest that inflammation and immune activation of MTC cells promote LNM and DM, and that higher values of NLR and Ctn concentration confer a high risk of metastasis.

Entities:  

Keywords:  calcitonin; distant metastasis; lymph node metastasis; medullary thyroid cancer; neutrophil-to-lymphocyte ratio; predictive factors

Year:  2018        PMID: 30546892      PMCID: PMC6256259          DOI: 10.3892/mco.2018.1727

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  38 in total

1.  Small medullary thyroid carcinoma: post-operative calcitonin rather than tumour size predicts disease persistence and progression.

Authors:  Katerina Saltiki; Gianna Rentziou; Kimon Stamatelopoulos; Georgios Georgiopoulos; Charalambos Stavrianos; Eirini Lambrinoudaki; Maria Alevizaki
Journal:  Eur J Endocrinol       Date:  2014-04-23       Impact factor: 6.664

2.  Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of survival in patients with metastatic urothelial carcinoma: A multi-institutional study.

Authors:  Satoru Taguchi; Tohru Nakagawa; Akihiko Matsumoto; Yasushi Nagase; Taketo Kawai; Yoshinori Tanaka; Kanae Yoshida; Sachi Yamamoto; Yutaka Enomoto; Yorito Nose; Toshikazu Sato; Akira Ishikawa; Yukari Uemura; Tetsuya Fujimura; Hiroshi Fukuhara; Haruki Kume; Yukio Homma
Journal:  Int J Urol       Date:  2015-04-22       Impact factor: 3.369

Review 3.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

4.  Usefulness of the neutrophil-to-lymphocyte ratio in predicting lymph node metastasis in patients with non-small cell lung cancer.

Authors:  Chongbiao Huang; Jie Yue; Zengxun Li; Na Li; Jinkun Zhao; Daliang Qi
Journal:  Tumour Biol       Date:  2015-04-29

5.  Blood neutrophil-to-lymphocyte ratio correlates with tumor size in patients with differentiated thyroid cancer.

Authors:  Chien-Liang Liu; Jie-Jen Lee; Tsang-Pai Liu; Yuan-Ching Chang; Yi-Chiung Hsu; Shih-Ping Cheng
Journal:  J Surg Oncol       Date:  2012-09-20       Impact factor: 3.454

6.  [Medullary thyroid cancer: surgical results and prognostic factors].

Authors:  D Dequanter; Ph Lothaire
Journal:  Rev Med Liege       Date:  2010 Jul-Aug

7.  Diagnostic utility of PET/CT with 18F-DOPA and 18F-FDG in persistent or recurrent medullary thyroid carcinoma: the importance of calcitonin and carcinoembryonic antigen cutoff.

Authors:  Ana Reyes Romero-Lluch; Juan Ignacio Cuenca-Cuenca; Raquel Guerrero-Vázquez; Antonio Jesús Martínez-Ortega; Juan Luis Tirado-Hospital; Isabel Borrego-Dorado; Elena Navarro-González
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-23       Impact factor: 9.236

8.  The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer.

Authors:  Herbert Chen; Rebecca S Sippel; M Sue O'Dorisio; Aaron I Vinik; Ricardo V Lloyd; Karel Pacak
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

Review 9.  Neutrophil-derived cytokines involved in physiological and pathological angiogenesis.

Authors:  Cristina Tecchio; Marco Antonio Cassatella
Journal:  Chem Immunol Allergy       Date:  2013-10-17

Review 10.  Thyroid cancer and inflammation.

Authors:  Valentina Guarino; Maria Domenica Castellone; Elvira Avilla; Rosa Marina Melillo
Journal:  Mol Cell Endocrinol       Date:  2009-10-14       Impact factor: 4.102

View more
  9 in total

1.  Predictors of distant metastases in sinonasal and skull base cancer patients treated with surgery.

Authors:  Cristina Valero; Dauren Adilbay; Conall W R Fitzgerald; Avery Yuan; Ximena Mimica; Piyush Gupta; Richard J Wong; Jatin P Shah; Snehal G Patel; Marc A Cohen; Ian Ganly
Journal:  Oral Oncol       Date:  2021-10-21       Impact factor: 5.337

2.  Predictive value of neutrophil-to-lymphocyte ratio for distant metastasis in gastric cancer patients.

Authors:  Dongmei Diao; Chengxue Dang; Xin Zhang; Xuan Wang; Wenxing Li; Tuanhe Sun
Journal:  Sci Rep       Date:  2022-06-17       Impact factor: 4.996

3.  Distant metastasis in oral squamous cell carcinoma: Does the neutrophil-to-lymphocyte ratio act as a surrogate of the host immune status?

Authors:  Daniella Karassawa Zanoni; Cristina Valero; Marlena R McGill; Pablo H Montero; Jatin P Shah; Richard J Wong; Ian Ganly; Snehal G Patel
Journal:  Oral Oncol       Date:  2021-12-01       Impact factor: 5.972

4.  Inflammatory biomarkers and dynamics of neutrophil-to-lymphocyte ratio in anaplastic thyroid carcinoma.

Authors:  Haruhiko Yamazaki; Kiminori Sugino; Kenichi Matsuzu; Chie Masaki; Junko Akaishi; Kiyomi Hames; Chisato Tomoda; Akifumi Suzuki; Takashi Uruno; Keiko Ohkuwa; Wataru Kitagawa; Mitsuji Nagahama; Munetaka Masuda; Koichi Ito
Journal:  Endocrine       Date:  2020-04-19       Impact factor: 3.633

5.  Inflammatory biomarkers and dynamics of neutrophil-to-lymphocyte ratio in lenvatinib treatment for anaplastic thyroid carcinoma.

Authors:  Haruhiko Yamazaki; Hiroyuki Iwasaki; Nobuyasu Suganuma; Soji Toda; Katsuhiko Masudo; Hirotaka Nakayama; Yasushi Rino; Munetaka Masuda
Journal:  Gland Surg       Date:  2021-03

6.  The value of neutrophil-to-lymphocyte ratio combined with the thyroid imaging reporting and data system in the diagnosis of the nature of thyroid nodules.

Authors:  Jie Zhang; Zhaoxia Gong; Shanshan Li; Ping Fan; Guanru Yue; Guilin Zou; Shasha He; Jiao Wang; Jixiong Xu
Journal:  J Clin Lab Anal       Date:  2022-04-11       Impact factor: 3.124

Review 7.  The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition.

Authors:  Gilda Varricchi; Stefania Loffredo; Giancarlo Marone; Luca Modestino; Poupak Fallahi; Silvia Martina Ferrari; Amato de Paulis; Alessandro Antonelli; Maria Rosaria Galdiero
Journal:  Int J Mol Sci       Date:  2019-08-13       Impact factor: 5.923

8.  Neutrophil-to-lymphocyte Ratio is Associated with LV Diastolic Dysfunction in the Overt Hyperthyroid Patients.

Authors:  Huan Zhang; Jiaoyue Zhang; Huan Li; Yaqiong Bi; Linfang Wang; Yuming Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-14       Impact factor: 6.055

Review 9.  Serum Inflammation-based Scores in Endocrine Tumors.

Authors:  Pedro Marques; Friso de Vries; Olaf M Dekkers; Márta Korbonits; Nienke R Biermasz; Alberto M Pereira
Journal:  J Clin Endocrinol Metab       Date:  2021-09-27       Impact factor: 5.958

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.